E-LIB Suche - Ergebnisse für: Krivak, T.

1

PD-0909 Outcome of multiple high-risk factors on overall su..:

Horne, Z. ; Abel, S. ; Crafton, S....
Radiotherapy and Oncology. 170 (2022) - p. S805-S806 , 2022

Link: https://doi.org/10.1016/..

2

OC-0299 Is pelvic radiation the right approach after surger..:

Horne, Z. ; Manire, M. ; Crafton, S....
Radiotherapy and Oncology. 161 (2021) - p. S205-S206 , 2021

Link: https://doi.org/10.1016/..

3

Ovarian Carcinosarcoma with Malignant Neuroectodermal Compo..:

Cheriyan, A ; Liu, Y ; Patel, S...
American Journal of Clinical Pathology. 154 (2020) Supplement_1 - p. S28-S28 , 2020

Link: https://doi.org/10.1093/..

4

PO-1142: Lymphadenectomy for vaginal melanoma, does it impr..:

Horne, Z. ; Teterichko, S. ; Wegner, R....
Radiotherapy and Oncology. 152 (2020) - p. S601-S602 , 2020

Link: https://doi.org/10.1016/..

5

Phase II OVARIO study of niraparib + bevacizumab therapy in..:

Hardesty, M.M. ; Krivak, T. ; Wright, G.S....
Gynecologic Oncology. 159 (2020) - p. 3-4 , 2020

Link: https://doi.org/10.1016/..

6

Platinum and taxane-induced ovarian damage in a mouse model..:

Berger, J.L. ; Beck, T. ; Mital, P....
Fertility and Sterility. 102 (2014) 3 - p. e149 , 2014

Link: https://doi.org/10.1016/..

7

Abstract 10: Comparison of outcomes in patients undergoing ..:

Quimper, M. ; Lesnock, J. ; Beriwal, S....
Gynecologic Oncology. 131 (2013) 1 - p. 282-283 , 2013

Link: https://doi.org/10.1016/..

8

Cost comparison of primary debulking surgery to neoadjuvant..:

Rowland, M. ; Farris, C. ; Lesnock, J..
Gynecologic Oncology. 130 (2013) 1 - p. e27 , 2013

Link: https://doi.org/10.1016/..

9

What is the role of retroperitoneal exploration in optimall..:

Rungruang, B. ; Miller, A. ; Krivak, T....
Gynecologic Oncology. 130 (2013) 1 - p. e9 , 2013

Link: https://doi.org/10.1016/..

10

Predictors and incidence of radical vulvectomy complication..:

Lin, J. ; Yu, M. ; Beriwal, S....
Gynecologic Oncology. 130 (2013) 1 - p. e38 , 2013

Link: https://doi.org/10.1016/..

11

The impact of facility volume on receiving standard of care..:

Lin, J. ; Berger, J. ; Krivak, T....
Gynecologic Oncology. 130 (2013) 1 - p. e18 , 2013

Link: https://doi.org/10.1016/..

12

Impact of preoperative and pretreatment CA125 on survival o..:

Horowitz, N. ; Miller, A. ; Rungruang, B....
Gynecologic Oncology. 130 (2013) 1 - p. e20 , 2013

Link: https://doi.org/10.1016/..

13

Neoadjuvant chemotherapy is less costly than primary debulk..:

Rowland, M. ; Farris, C. ; Lesnock, J..
Gynecologic Oncology. 131 (2013) 1 - p. 278-279 , 2013

Link: https://doi.org/10.1016/..

14

A chemoresponse assay for prediction of platinum resistance..:

Krivak, T. ; Secord, A. Alvarez ; Richard, S....
Gynecologic Oncology. 131 (2013) 1 - p. 276 , 2013

Link: https://doi.org/10.1016/..

15

Abstract 12: Prognostic indicators, including role of surge..:

Lin, J. ; Beriwal, S. ; Olawaiye, A...
Gynecologic Oncology. 131 (2013) 1 - p. 283 , 2013

Link: https://doi.org/10.1016/..